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Objective:	  To	   report	   signalment,	   clinical	   signs,	   preoperative	   staging	   tests,	   histologic	   diagnosis,	   surgical,	  
and	   oncologic	   outcomes	   including	   postoperative	   limb	   use,	   in	   dogs	   with	   scapular	   tumors	   treated	   by	  
scapulectomy.	   Study	   Design:	   Retrospective	   case	   series	   Animals:	   Dogs	   (n	   =	   42)	   with	   scapular	  
tumors.Methods:	  Medical	   records	   (1995-­‐2010)	   from	   6	   hospitals	   were	   searched	   for	   dogs	  with	   scapular	  
tumors	   treated	   by	   scapulectomy.	   Data	   retrieved	   were:	   signalment,	   weight,	   percentage	   of	   scapula	  
removed,	  histologic	  diagnosis,	  postoperative	   limb	  use,	  adjunctive	  therapy,	  disease	   free	   interval	   (DFI),	  
and	   survival	   time	   (ST).	   Individual	   variables	   were	   modeled	   with	   a	   Cox	   proportional	   hazard	   model	  
accounting	   for	   censoring	   to	   determine	   risk	   factors	   for	   decreased	   DFI	   and	   ST.	   For	   categorical	   variables,	  
Kaplan-­‐Meier	   survival	   plots	   as	   well	   as	  mean	   and	  median	   survival	   5mes	   (MSTs)	   were	   calculated.	  Results:	  
Subtotal	   scapulectomy	   was	   performed	   in	   18	   dogs	   (42.9%).	   Osteosarcoma	   (OSA)	   was	   diagnosed	   in	   27	  
dogs	  (64.3%).	  Limb	  use	  was	  evaluated	  immediately	  after	  surgery	  in	  41	  dogs.	  Information	  on	  limb	  use	  at	  
other	  times	  (1,	  2,	  3,	  and	  >3	  months)	  postoperatively	  was	  also	  available	  for	  some	  dogs	  and	  was	  good	  to	  
excellent	  overall.	  Only	  adjunc5ve	  chemotherapy	  had	  a	  posi5ve	  significant	  effect	  on	  DFI	  (P	  =	  .00011)	  and	  ST	  
(P	  =	  .0003).	  Conclusion:	  Canine	  scapular	  tumors	  can	  be	  treated	  effectively	  by	  scapulectomy	  and	  limb	  use	  
is	  fair	  to	  excellent	  for	  most	  dogs.	  OSA	  was	  the	  most	  common	  scapular	  tumor.	  Overall	  prognosis	  for	  scapular	  
OSA	   is	   similar	   to	   appendicular	  OSA	   at	   other	   sites	   and	   use	   of	   adjunctive	   chemotherapy	   prolonged	   the	  
overall	  DFI	  and	  MST.	  
Malignant	   tumors	   affecting	   the	   scapula	   are	   rare	   in	   dogs	   and	   affected	   dogs	   are	   often	   treated	   with	  
forelimb	   amputation.	   Limb-­‐sparing	   surgery	   is	   an	   alternative	   for	   tumors	   affecting	   the	   scapula	   in	   people,	  
d o g s	   a n d	   c a t s .	  
In	   1894,	   Syme	   reported	   scapulectomy	   for	   tumor	   removal	   in	   people	   with	   minimal	   complications	   and	  
maintenance	  of	  a	  func5onal	  arm.	  Limb-­‐sparing	  using	  endoprosthe5c	  replacement	  of	  the	  scapula	  after	  wide	  
resection	   of	   scapular	   tumors	   is	   a	   surgical	   technique	   that	   is	   also	   currently	   performed	   in	   people.5	   The	  
scapula	  can	  also	  be	  completely	  excised,	  maintaining	  limb	  function	  without	  an	  endoprosthesis	  or	  allograft	  
replacement	  in	  both	  people	  and	  animals.2	  There	  are	  major	  differences	  in	  the	  structure	  and	  function	  of	  the	  
shoulder	  joint	  in	  people	  and	  dogs,	  but	  it	  appears	  that	  both	  species	  tolerate	  this	  procedure	  as	  a	  method	  of	  
limb	  salvage.	  In	  people,	  the	  shoulder	  is	  the	  third	  most	  common	  site	  for	  musculoskeletal	  neoplasia.	  6	  Bone	  
tumors	   of	   the	   shoulder	   joint	   in	   people	  occur	   in	   either	   the	  proximal	   aspect	   of	   the	   humerus,	   scapula,	   or	  
clavicle	   in	  decreasing	  order	  of	  frequency,	  with	  soft	   tissue	   tumors	  being	  most	  commonly	   located	  in	  the	  
deltoid	  or	  supraspinatus	  muscles.7	  In	  14	  people,	  it	  was	  reported	  that	  resection	  of	  80%	  of	  the	  scapula	  had	  
only	  a	  modest	  effect	  on	  arm	  function.	  These	  authors	  also	  reported	  that	  subtotal	  scapulectomy	  provided	  an	  
excellent	   functional	   result	   if	   all	   or	   part	   of	   the	   glenohumeral	   joint	   could	   be	   preserved.8	  
Scapulectomy	   is	   rarely	   performed	   in	   animals	   for	   tumors	   affecting	   the	   scapula,	   because	   most	   dogs	  
function	  well	   afterlimb	   amputation.	   If	   a	  mass	   can	   be	   removed	  with	   curative	   intent	  by	   scapulectomy,	  
the	   technique	   advantage	   is	   that	   wide	   surgical	   excision	   can	   be	   achieved	   with	   preservation	   of	   limb	  
function.	  There	  is	  a	  paucity	  of	   information	  on	  scapulectomy	  in	  dogs	  and	  cats	  with	  4	  reports	  collectively	  
describing	   this	   procedure	   in	   14	  dogs	   and	  2	   cats.1"3'9	   The	   surgical	   technique,	   described	   by	   Trout	   et	   al.,3	  
resulted	   in	   good	   to	   excellent	   postoperative	   limb	   function	   in	   6/6,	   4/5,	   3/4,	   and	   1/1	   cases.1"3'9	  Of	   the	   14	  
dogs,	   7	   had	   partial,	   6	   subtotal,	   and	   1	   scapulectomy	   1~3'9;	   histologic	   diagnoses	   were	   OSA	   (n	   =	   5),	  
chondrosarcoma	   (CSA;	   3),	   hemangiosarcoma	   (HSA;	   3),	   and	   softtissue	   sarcoma	   (STS;	   3).1"3'9	  
OSA	   is	   the	   most	   frequently	   diagnosed	   primary	   bone	   tumor	   in	   dogs,	   accounting	   for	   ~85%	   of	   skeletal	  
tumors;	  >75%	  OSA	  affect	  long	  bones	  of	  the	  appendicular	  skeleton.	  10Hammer	  et	  al.	  reported	  6	  (13%)	  of	  45	  
dogs	  with	  OSA	  of	   flat	   and	   irregular	  bones	   had	   scapular	   involvement.11	  OSA	  was	   the	  most	   frequently	  
reported	  primary	  bone	  tumor	  of	  the	  scapula	   in	  dogs	  and	  cats	  that	  had	  scapulectomy.1"3	  CSA	  is	  the	  2nd	  
most	  common	  primary	  bone	  tumor	  of	  dogs.10	  Of	  16	  scapulectomy	  procedures	  in	  dogs	  and	  cats,	  3	  were	  for	  
CSA1"3'9	  despite	  the	  scapula	  being	  a	  rare	  site	  ofCSA.12	  Only	  1	  case	  of	  scapula	  CSA	  was	  identified	  in	  Waltman	  
et	   al.'s	   31	   non-­‐nasal	   CSAs13	   and	   scapular	   tumors	   were	   excluded	   by	   Farese	   et	   al.14	   in	   25	   canine	  
appendicular	   CSA	   treated	   by	   amputation.	   Our	   purpose	   in	   this	   retrospective,	   multi-­‐institutional	  
Veterinary	   Society	   of	   Surgical	   Oncology	   (VSSO)	   study	   were:	   (1)	   to	   report	   signalment	   and	   outcome	  
data	   from	  a	  relatively	  large	  number	  of	  dogs	  with	  tumors	  of	  the	  scapula	  that	  were	  treated	  with	  partial	  or	  
total	   scapulectomy;	   (2)	   document	   presenting	   clinical	   signs,	   preoperative	   staging,	   histologic	   diagnosis,	  
potential	  prognostic	  factors,	  and	  postoperative	  limb-­‐use;	  and	  (3)	  define	  disease	  free	  interval	  (DFI)	  and	  
survival	  time	  (ST).	  We	  postulated	  that	  scapulectomy	  can	  be	  performed	  with	  minimal	  complications	  and	  
that	  it	  is	  an	  effective	  limb	  sparing	  alternative	  to	  amputation	  in	  dogs	  with	  tumors	  of	  the	  scapula.	  	  
MATERIALS	  AND	  METHODS	  
This	  study	  was	  initiated	  by	  requesting	  case	  submissions	  from	  VSSO	  members	  through	  the	  VSSO	  research	  
committee	  and	   list-­‐serve.	  Medical	   records	   (1995-­‐2010)	   from	  contributing	   institutions	  were	  searched	  to	  
identify	   dogs	   that	   had	   scapulectomy.	   Inclusion	   criteria	   were	   dogs	   with	   histopathologically	   confirmed	  
tumors	   of	   the	   scapula	   treated	   by	   partial	   or	   total	   scapulectomy.	   Data	   retrieved	  were:	   sex,	   breed,	   age,	  
weight,	  clinical	  signs,	  scapula	  affected,	  dates	  of	  presentation	  and	  surgery,	  pre-­‐	  and	  postoperative	  serum	  
alkaline	  phosphate	  concentrations,	  clinical	  staging,	  preoperative	  diagnostic	  tests,	  approximate	  percentage	  
of	   scapula	   resected	   (partial,	   subtotal,	   or	   total	   scapulectomy),	   histopathologic	   diagnosis	   and	   surgical	  
margin	   evaluation,	   postoperative	   surgical	   complications	   (acute	   <1	   month;	   chronic	   >1	   month),	  
postoperative	   limb	   use,	   adjunctive	   therapy,	   whether	   or	   not	   physiotherapy	   was	   performed,	   date	   of	  
detection	  of	  local	  recurrence	  or	  distant	  metastatic	  disease,	  and	  date	  and	  cause	  of	  death.	  
Partial	   scapulectomy	   was	   defined	   as	   removal	   of	   <75%	   of	   the	   scapula,	   subtotal	   scapulectomy	   as	  
removal	  of	  >75%	  of	  the	  scapula,	  with	  preservation	  of	  the	  glenoid	  of	  the	  scapula,	  and	  total	  scapulectomy	  
as	   removal	   of	   the	   entire	   scapula,	   including	   the	   glenoid.	   Case	   contributors	   were	   asked	   to	   mark	   the	  
osteotomy	  or	  excision	  site	  on	  a	  diagram	  used	   for	  case	  accrual.	  From	  the	  diagram,	   the	  percentage	  of	   the	  
scapula	  removed,	  was	  subjectively	  classified	  as	  50%,	  75%,	  or	  100%.	  Histopathologic	  diagnosis	  was	  based	  on	  
the	   original	   assessment	   by	   the	   a^ending	   pathologist	   at	   the	   time	   of	   specimen	   submission.	   A	   complete	  
histologic	  margin	  of	   excision	  was	  defined	  as	  no	  neoplas5c	   cells	   found	   <5mm	   from	   the	   surgical	  margins.	  
Clean	   but	   close	   histologic	   margins	   were	   defined	   as	   neoplastic	   cells	   visible	   2—	   5mm	   from	   the	   surgical	  
margins.	  Incomplete	  margins	  were	  defined	  as	  neoplas5c	  cells	  within	  2	  mm	  of	  the	  surgical	  margins.	  
Postoperative	   limb	  use,	  based	  on	  subjective	  evaluation	  by	  case	  contributors,	  was	  categorized	  using	  a	  
lameness	  scale15	  as:	  poor	  (non-­‐weight	  bearing	  lameness),	  fair	  (slight	  to	  moderate	  lameness	  but	  consistent	  
weight	   bearing),	   good	   (slight	   lameness	   only	   after	   extensive	   exercise),	   and	   excellent	   (normal	   limb	  
function).	   Limb	   use	   was	   evaluated	   within	   14	   days,	   within	   1,	   2,	   and	   3	   months	   and	   >3	   months	  
postoperatively.	  
Oncologic	  outcome	  measures	  were:	  DFI	  and	  ST.	  DFI	  was	  defined	  as	  time	  from	  scapulectomy	  until	  date	  
of	  first	  evidence	  of	  distant	  metastasis	  or	  local	  tumor	  recurrence.	  ST	  was	  time	  between	  scapulectomy	  and	  
death.	   Cause	   of	   death	   was	   classified	   as	   either	   tumor-­‐related	   or	   non-­‐tumor	   related.	   Dogs	   with	   an	  
unknown	   cause	   of	   death	   were	   presumed	   to	   have	   died	   from	   tumor-­‐related	   causes.	   Dogs	   that	   died	  
because	  of	  non-­‐tumor	  related	  causes	  or	  were	   lost	  to	  follow	  up	  were	  censored	  for	  the	  survival	  analysis.	  
Individual	  dog	  and	  surgical	  variables	  were	  modeled	  with	  a	  Cox	  proportional	  hazard	  model,	  accounting	  for	  
censoring,	  to	  determine	  risk	  factors	  for	  DFI	  and	  ST.	  For	  categorical	  variables,	  Kaplan-­‐Meier	  survival	  plots	  
as	  well	  as	  mean	  and	  median	  STs	  were	  calculated.	  A	  Spearman	  correlation	  analysis	  was	  used	  to	  test	  for	  an	  
association	  between	  body	  weight	  and	   limb	  use.	  ANO	  VA	  was	  used	   to	  determine	   if	  mean	  weights	  were	  
significantly	   different	   between	   tcategories	   of	   limb	   use.	   An	   exact	   logistic	   regression	   test	   was	   used	   to	  




Forty-­‐two	   dogs	   (median	   age,	   8.3	   years	   [range,	   1.5-­‐13	   years];	   medianweight,	   34.8kg	   [range,	   10.5-­‐57.7	  
kg)met	   the	   inclusion	   criteria	   (Table	   S1).	   There	  were	  24	  males	   (15	   intact,	   9	   castrated)	   and	   18	   females	   (9	  
intact,	   9	   spayed).	   Affected	   breeds	   were:	   Labrador	   retrievers	   (n	   =	   7);	   Rottweiler	   (5);	   3	   each	   of	   golden	  
retrievers,	   border	   collies	   and	   mixed	   breed	   dogs;	   2	   each	   of	   boxers,	   German	   shepherd	   dogs,	   great	  
Pyrenees	   andmalamutes;	   and	   1	   each	   of	   the	   giant	   schnauzer,	   miniature	   schnauzer,	   Doberman,	   bull	  
mastiff,	  basset	  hound,	  old	  English	  sheepdog,	  beagle,	   standard	  poodle,	  English	   setter,	  Australian	  heeler,	  
Tibetan	  terrier,	  Airedale,	  and	  great	  Dane.	  
Presenting	  Complaint	  
Lameness	  (36	  dogs;	  86%)	  was	  the	  most	  common	  presenting	  complaint.	  A	  visible	  scapular	  mass	  or	  swelling	  
was	  observed	   in	  14	   dogs	   (33%)	   and	   both	   lameness	   and	   a	   swelling	   or	  mass	  was	  noted	   in	   8	   dogs	   (19%).	  
There	  was	  no	  difference	  in	  laterality	  of	  the	  scapula	  affected	  with	  23	  (57.5%)	  tumors	  in	  the	  left	  scapula	  and	  
17	  (42.5%)	  in	  the	  right.	  
Concurrent	   disease	   was	   present	   in	   11	   dogs;	   8	   had	   concurrent	   degenerative	   joint	   disease	   and	   3	  
another	   neoplastic	   disease,	   including	   oral	   fibrosarcoma	   (FSA)	   incompletely	   removed	   and	   a	  mammary	  
tumor	   with	   lymphatic	   infiltration	   (dog	   8).	   Dog	   30	   had	   a	   cutaneous	   basosquamous	   carcinoma	   with	  
metastasis	  to	  the	  draining	  lymph	  node	  removed	  and	  dog	  35	  had	  an	  oral	  melanoma	  of	  the	  lower	  lip,	  which	  
was	  removed	  1	  year	  earlier	  and	  had	  adjuvant	  therapy	  with	  a	  melanoma	  vaccine.	  
Preoperative	  Diagnostic	  Tests	  
Preoperative	   imaging	   for	   clinical	   staging	  purposes	   included:	   3	   projection	   thoracic	   radiographs	   (n	   =	   39),	  
long	   bone	   survey	   radiographs	   (11)	   and	   whole	   body	   nuclear	   scintigraphic	   bone	   scan	   (13).	   Thoracic	  
radiographs	  werenormal	  in	  37	  dogs;	  2	  dogs	  (5%)	  (dogs	  6	  and	  3	  6)	  had	  pulmonary	  metasta5c	  disease	  evident	  
on	  thoracic	  radiographs.	  No	  additional	  bone	   lesions	  were	   identified	  on	   long	  bone	  survey	  radiographs.	  
Dog	   22	   had	   increased	   radiopharmaceutical	   uptake	   in	   the	   ipsilateral	   distal	   radius;	   bone	  metastasis	  was	  
ruled	   out	   on	   subequent	   evalutation.	   On	   scintigraphic	   examination	   175	   days	   after	   scapulectomy,	   there	  
was	   no	   increased	   uptake	   in	   the	   ipsilateral	   radius.	   Advanced	   imaging	   for	   local	   staging	   and	   surgical	  
planning	   was	   performed	   in	   18	   dogs;	   16	   had	   computed	   tomography	   (CT)	   scans	   performed	   and	   2	   had	  
magnetic	  resonance	  imaging	  (MRI)	  studies.	  Absence	  of	  an	  advanced	  imaging	  study	  preoperatively	  did	  not	  
increase	  the	  risk	  of	  incomplete	  excision.	  (P	  =	  .64).	  
Cytologic	   examination	   of	   preoperative	   fine	   needle	   aspiration	   of	   the	   mass	   in	   11	   dogs	   identified	  
sarcoma	  (n	  =	  6),	  OSA	  (4)	  and	  HSA	  (1).	  Preoperative	  incisional	  biopsy	  for	  histopathology	  was	  performed	  in	  
27	  dogs:	  OSA	  (n	  =	  15),	  CSA	  (4),	  FSA	   (3),	  STS	   (2),	  HSA	  (1),	  histiocytic	  sarcoma	  (HS;	  1),	  and	  nondiagnostic	  
(1).	  
Scapulectomy	  
Partial	   scapulectomy	   was	   performed	   in	   24	   dogs,	   subtotal	   scapulectomy	   (with	   preservation	   of	   the	  
glenoid,	  Fig	  1)	  in	  13,	  and	  total	  scapulectomy	  (entire	  scapula	  removed	  including	  glenoid)	  in	  5	  dogs	  (dogs	  
3,	  4,	  25,	  26,	  and	  28).	  In	  2	  total	  scapulectomy	  dogs,	  en	  bloc	  resection	  of	  the	  humeral	  head	  (dog	  28,	  Fig	  2),	  
and	   a	   rib	   (dog	   29),	   respectively,	   were	   performed	   at	   the	   time	   of	   surgery.	   The	   percentage	   of	   scapula	  
removed	  was	  <50%	  in	  8	  dogs,	  50-­‐75%	  in	  16	  dogs,	  and	  >75%	  in	  18	  dogs.	  	  
Adjuvant	  Therapy	  
Thirty-­‐one	   (73.8%)	  dogs	  were	  administered	  chemotherapy.	  Protocols	   included	  single	  agent	   treatment	  
with	  doxorubicin,	  epirubicin	  or	  a	  platinum	  agent,	  and	  alternating	  agents	  with	  doxorubicin	  or	  epirubicin	  
and	   a	   platinum	   agent.	   Nineteen	   (61.3%)	   dogs	   had	   a	   complete	   treatment	   course	   of	   4-­‐6	   cycles	   of	  
chemotherapy	   (Table	   S1).	   Of	   dogs	   administred	   chemotherapy,	   24	   had	   OSA,	   3	   STS	   (grade	   II	   STS,	  
undifferentiated	  sarcoma	  and	  FSA),	  and	  1	  each	  had	  CSA,	  HSA,	  HS,	  and	  skeletal	  angiomatosis.	  Dog	  24	  had	  
metronomic	  chemotherapy	  after	  full	  course	  chemotherapy	  and	  the	  chemotherapy	  protocol	  used	  for	  dog	  
33	   was	   not	   recorded.	   Additional	   medical	   treatments	   were	   reported.	   Four	   dogs	   were	   administered	  
nonsteroidal	  anti-­‐inflammatory	  drugs	  (NSAIDs)	  and	  2	  dogs	  (dogs	  33	  and	  36)	  had	  radiation	  therapy.	  Dog	  33	  
had	   an	   incomplete	   FSA	   remo	   val	   and	   had	   full	   course	   fractionated	   radiotherapy	   (3	   Gy	   x	   19)	   started	   3	  
weeks	  after	  surgery.	  Dog	  36	  had	  palliative	  radiotherapy	  (8	  Gy	  x	  2	  on	  consecutive	  days)	  before	  surgery.	  
Surgical	  Outcome	  
Postoperative	   complications	   included	   surgical	   site	   complica-­‐tions,	   impaired	   limb	   use,	   and	   local	  
recurrence.	   Fourteen	   (35%)	   of	   40	   dogs	   had	   acute	   complications;	   7	   dogs	   developed	   seroma.	   A	   closed-­‐
suc5on	  drain	  was	  placed	  in	  dog	  11	  for	  5	  days.	  Dog	  34	  had	  suture	  breakdown	  between	  the	  scapula	  and	  the	  
serratus	  ventralis	  muscle	  remnant.	  Six	  dogs	  were	  very	  lame	  with	  intermittent	  weight	  bearing	  within	  the	  
first	   48hours	   after	   surgery.	   Six	   (15%)	  of	  39	  dogs	  developed	  chronic	   complications.	   In	   2	  dogs	   (dogs	  23	  
and	  39)	  seroma	  occurred	  at	  the	  surgical	  site	  >	  1	  month	  postoperatively.	  Dog	  29	  (grade	  II	  STS	  and	  en	  bloc	  
rib	   resection)	   developed	   pneumothorax	   30	   days	   after	   surgery.	   Three	   dogs	   were	   lame	   1	   month	  
postoperatively;	   dog	   8	   had	   a	   CT	   scan	   twice	  within	   1	  month	  because	  of	   lameness.	   Local	   recurrence	   was	  
suspected	  because	  of	  evidence	  of	  osteolysis	  at	  the	  site	  of	  the	  scapular	  osteotomy	  on	  CT	  scan.	  This	  dog	  
had	  an	  incisional	  biopsy	  performed,	  but	  recurrence	  was	  not	  confirmed	  histologically	  and	  the	  dog	  was	  lost	  
to	  follow	  up	  313	  days	  after	  initial	  surgery.	  
Limb	  Use	  
Of	  41	  dogs	  with	  limb	  use	  information	  within	  14	  days	  of	  surgery,	  15	  were	  considered	  to	  have	  poor	  limb	  
use,	  17	   fair;	  7	  good;	  and	  2	  excellent	   limb	  use.	   Forty-­‐one	  dogs	  were	  examined	  during	   the	  1st	  month	  
postoperatively.	  Limb	  use	  was	  poor	  (n	  =	  8),	  fair	  (17),	  good	  (12),	  and	  excellent	  (4).	  Information	  regarding	  
limb	  use	  up	  to	  2	  months	  postoperatively	  was	  available	  for	  14	  dogs	  and	  limb	  use	  was	  described	  as	  poor	  (1),	  
fair	   (3),	  good	   (4),	  and	  excellent	   (6)	   in	   this	  group	  of	  dogs.	   Informa5on	  regarding	   limb	  use	  up	  to	  3	  months	  
postsurgery	   was	   available	   for	   6	   dogs	   and	   was	   good	   in	   4	   dogs	   and	   excellent	   in	   2	   dogs.	   In	   9	   dogs,	  
information	  was	  available	  regarding	  limb	  use	  >3months	  (4-­‐10	  months)	  postoperatively	  and	  was	  good	  in	  
1	  dog	  and	  excellent	  in	  8	  dogs	  (Table	  1).	  No	  correla5on	  between	  %	  scapula	  removed	  and	  limb	  use	  at	  14	  days	  
and	   1	   month	   was	   identified.	   A	   significant	   negative	   association	   (Spearman	   correlation	   analysis)	   was	  
found	  between	  increasing	  body	  weight	  and	  postoperative	   limb	  use	   in	   the	   first	  14	  days	   (P	  =	  .0045;	  
Fig	  3)	  Eight	  dogs	  (dogs	  14,	  23,	  25,	  32,	  33,	  34,	  40,	  and	  42)	  had	  postoperative	  physiotherapy	  once	  weekly	  
and	  all	  had	   subjective	   improvement	   in	   limb	  use	  during	  physiotherapy	  except	   for	  dog	  25	   that	  had	  good	  
use	   of	   the	   limb	   immediately	   after	   surgery	   and	   did	   not	   show	   additional	   signs	   of	   improvement	   during	  
physiotherapy.	  
Follow	  up	  and	  evaluation	  was	  not	  standardized	  and	  was	  based	  on	  the	  clinical	  evaluation	  of	  each	  dog.	  
Fifty	   percent	   of	   the	   dogs	  with	   poor	   limb	  use	   at	   1	  month	  had	   improvement	   in	   limb	  use	   at	   subsequent	  
rechecks	  with	  2	  having	  good	  limb	  use	  and	  2	  excellent	  limb	  use.	  The	  follow	  up	  time	  for	  the	  other	  dogs	  that	  
had	  poor	  limb	  use	  ranged	  from	  60	  to	  1195	  days.	  Although	  information	  on	  ST	  was	  available	  for	  these	  dogs,	  
we	  did	  not	  always	  have	  information	  on	  limb	  use.	  Ten	  of	  17	  dogs	  with	  fair	  limb	  use	  during	  the	  1st	  month	  
had	  improvement	  in	  limb	  at	  subsequent	  reevaluations;	  5	  had	  good	  limb	  use	  and	  5	  excellent	  limb	  use.	  
Histologic	  Outcome	  
Forty-­‐one	   scapulae	   were	   examined;	   27	   had	   OSA,	   7	   STS,	   4	   CSA,	   2	   HSA	   and	   1	   HS,	   and	   1	   skeletal	  
angiomatosis.	  Of	  STS	  cases,	  4	  were	  not	  further	  subclassified	  but	  were	  diagnosed	  as	  grade	  II	  STS	  (2),	  grade	  
I	   STS	   (1)	   and	   undifferentiated	   STS	   (1),	   and	   3	   were	   classified	   as	   FSA.	   Dog	   38	   had	   CSA	   diagnosed	   on	  
preoperative	  incisional	  biopsy,	  but	  he	  operative	  specimen	  was	  lost.	  Of	  34	  dogs	  that	  had	  histologic	  margin	  
evaluation,	   28	   (82.4%)	   had	   complete	   surgical	  margins	   and	   6	   (17.6%)	   had	   incomplete	   surgical	  margins	  
(dogs	  3,	  8,	  17,	  24,	  and	  33).	  
Oncologic	  Outcome	  
Local	   tumor	   recurrence	  was	   reported	   in	   2	   dogs	   and	   suspected	   in	   1	   dog.	   Dog	   28	   had	   FSA	   and	   complete	  
margins,	   and	   for	   dog	   38,	   the	   preopera5ve	   biopsy	   was	   consistent	   with	   CSA,	   but	   there	   was	   no	   final	  
histopathology	   report	   with	   margin	   assessment.	   In	   dog	   8,	   there	   was	   suspected	   local	   recurrence	   at	   4	  
months.	  This	  dog	  developed	  lameness	  and	  a	  painful	  mass	  was	  found	  on	  palpation	  of	  the	  previous	  surgical	  
site.	  Partial	  scapulectomy	  was	  used	  to	  remove	  a	  fibroblastic	  OSA	  initially;	  however,	  the	  margins	  were	  incomplete.	  
Revision	  of	  a	  previous	  maxillectomy	  for	  an	   incompletely	  excised	  oral	  FSAwas	  also	  perfomed	  at	  the	  time	  of	  partial	  
scapulectomy.	  Postoperative	  CT	  scan	  of	  the	  affected	  site	  was	  performed	  at	  4	  and	  5	  months.	  The	  4	  month	  CT	  scan	  
had	  lysis	  of	   the	  scapula,	  0.5	  cm	  from	  to	  the	  scapulectomy	  osteotomy	  site.	  One	  month	  later,	  there	  was	  more	  
periosteal	   proliferation	   of	   the	   remaining	   scapula	   without	   bone	   lysis	   and	   an	   open	   incisional	   biopsy	   revealed	  
regenerative	  hematopoiesis.	   Further	  diagnostic	  work	  up	  of	   this	   lesion	  was	  not	  performed.	   This	   dog	  was	   lost	   to	  
follow	  up	  313	  days	  after	  scapulectomy.	  
Follow-­‐up	  thoracic	  radiographs	  were	  available	  at	  various	  5mes	  for	  30	  (71.4%)	  dogs.	  Pulmonary	  metastasis	  was	  
diagnosed	  radiographically	  in	  20	  (66.6%);	  16	  had	  OSA,	  2	  CSA	  (dogs	  35	  and	  38),	  1	  FSA	  (dog	  30),	  and	  1	  grade	  IISTS	  
(dog	  32).	  In	  3	  of	  20	  dogs	  with	  lung	  metastasis	  (dogs	  20,	  22	  with	  OSA,	  and	  dog	  30	  with	  FSA),	  bone	  metastasis	  was	  also	  
found	  as	  an	  incidental	  radiographic	  finding	  (dogs	  20	  and	  30)	  and	  on	  whole	  body	  nuclear	  scintigraphy	  (dog	  22;	  Table	  
S1).	  Dog	  25	  with	  lung	  and	  bone	  metastasis	  noted	  on	  chest	  radiographs	  and	  total	  body	  scintigraphy,	  had	  abdominal	  
ultrasonography	  and	  splenic	  and	  hepatic	  masses	  consistent	  with	  metastatic	  OSA	  confirmed	  by	  ultrasound	  guided	  
fine	  needle	  aspiration	  and	  cytology.	  In	  3	  of	  these	  4	  dogs	  (dogs	  20,	  22,	  and	  25)	  a	  whole	  body	  scan	  was	  performed	  
preoperatively.	  In	  1	  dog,	  (dog	  33,	  with	  FSA)	  a	  neoplastic	  pleural	  effusion	  on	  cytology	  and	  a	  mediastinal	  mass	  were	  
found.	   Several	  biopsies	  were	   taken	   from	   the	  mass	   thoracoscopically	   and	   they	  were	   compatible	  with	   the	  primary	  
tumor.	  In	  dog	  41	  with	  HS	  of	  the	  scapula,	  cytologically	  confirmed	  metastasis	  developed	  in	  both	  the	  skin	  and	  spleen.	  
Dog	  14	  with	  OSA	  developed	  bone	  metastasis	  involving	  the	  spinous	  process	  of	  C5	  radiographically	  (Table	  S1).	  
Overall	  DFI	  was	  204	  days	  (range,	  107-­‐245	  days)	  and	  MST	  was	  246	  days	  (range,	  177-­‐394	  days).	  Nineteen	  dogs	  
died	  from	  tumor	  related	  causes.	  Twenty-­‐three	  dogs	  were	  censored	  for	  survival	  analysis;	  11	  dogs	  were	  lost	  to	  follow	  
up,	  3	  dogs	  were	  still	  alive	  at	  time	  of	  writing;	  4	  dogs	  died	  for	  unknown	  reasons;	  and	  5	  from	  unrelated	  causes.	  One	  of	  
these	  dogs	  (dog	  4)	  had	  hemoabdomen	  but	  necropsy	  was	  not	  performed	  and	  dog	  2	  was	  euthanatized	  because	  of	  
hypertrophic	  cardiomyopathy	  and	  caval	  thrombus.	  
In	   univariate	   analysis,	   age,	   sex,	   weight,	   presenting	   complaint,	   lameness	   duration	   before	   surgery,	   limb	  
involved	  (right	  and	  left),	  %	  scapula	  removed,	  ALP	  concentration,	  histopathologic	  margins	  and	  diagnosis	  were	  not	  
significantly	  associated	  with	  DFI	  or	  median	  ST.	  ST	  was	  significantly	  positively	  associated	  with	  administration	  of	  
chemotherapy	  (P	  =	  .0003,HR	  =	  5.45;95%CI:2.2,	  13.5)	  with	  a	  median	  STof	  269	  days	  (range,	  232-­‐919	  days)	  in	  dogs	  
that	  were	  administered	  chemotherapy	  compared	  with	  107	  days	  (range,	  49-­‐122	  days)	  for	  those	  that	  did	  not.	  DFI	  was	  
also	  significantly	  and	  favorably	  associated	  with	  administration	  of	  adjunctive	  chemotherapy	  (P	  =	  .0011,HR	  =	  38.2;	  
95%CI:	  4.2,	  339.6)	  with	  dogs	  that	  had	  chemotherapy	  having	  median	  DFI	  of	  211	  days	  (range,	  13	  9-­‐366	  days)	  compared	  
with	  52	  days	  (range,	  39-­‐107	  days)	  in	  dogs	  that	  did	  not.	  
DFI	  and	  median	  ST	  in	  dogs	  diagnosed	  with	  scapula	  OSA	  were	  210	  days	  (range,	  118-­‐245	  days)	  and	  246	  days	  (range,	  
177-­‐651	  days),	  respectively.	  When	  dogs	  with	  OSA	  were	  evaluated	  as	  a	  group,	  administration	  of	  chemotherapy	  did	  
not	   have	   a	   statistically	   significant	   positive	   effect	   on	   DFI	   or	   median	   ST.	   A	   positive	   effect	   on	   survival	   with	  
chemotherapy	  administration	  was	  suggested,	  as	  this	  comparison	  approached	  significance.	  (P	  =	  .056,	  HR=	  16.183).	  
In	  dogs	  with	  STS,	  DFI	  was	  366	  days	  (range,	  107-­‐366	  days)	  and	  ST	  was	  412.5	  days	  (range,	  107-­‐2342).	  Dogs	  with	  CSA	  
had	  a	  DFI	  of	  54.5	  days	  (range,	  46-­‐63	  days)	  and	  the	  median	  ST	  was	  not	  reached	  but	  the	  mean	  ST	  time	  was	  108	  days	  
(Table	  2).	  
DISCUSSION	  
We	  found	  that	  the	  signalment	  of	  dogs	  was	  consistent	  with	  previous	  reports	  of	  dogs	  with	  primary	  bone	  tumors.	  
Affected	   dogs	  were	  middle-­‐aged	   to	   older,	   large	   breed	   dogs	   of	   various	  breeds.	   The	  most	   common	   presenting	  
complaints	  were	  lameness	  (86%),	  swelling	  in	  the	  scapular	  region	  (33%)	  or	  both	  lameness	  and	  swelling.	  Based	  
on	  this	  finding,	  we	  recommend	  that	  every	  orthopedic	  examination	  should	  include	  careful	  palpation	  of	  the	  scapula	  
to	   ensure	   that	   this	   relatively	   rare	   diagnosis	   is	   not	   missed.	   In	   most	   (81%)	   dogs,	   >50%	   of	   the	   scapula	   was	  
removed,	   suggesting	   that	   a	   relatively	   large	   amount	   of	   the	   scapula	   is	   affected	   before	   diagnosis.	  With	   the	  
tumor	  types	   in	  our	  dogs,	  3	  cm	  margins	  are	  advisable	   to	  achieve	  complete	  margins	  of	  excision,	  so	  even	  a	  small	  
lesion	   can	   result	   in	   removal	   of	   half	   of	   the	   scapula	   or	  more,	   depending	   of	   the	   size	   of	   the	   dog.	   The	   %	   scapula	  
removed	  was	  not	  associated	  with	   limb	  use	  postoperatively	  or	  at	  1	  month	  after	  surgery.	  Further,	  the	  %	  scapula	  
removed	  was	  not	  associated	  with	  DFI	  or	  ST.	  Five	  dogs	  had	  a	  total	  scapulectomy	  and	  1	  of	  these	  involved	  en	  bloc	  
resection	  of	  the	  humeral	  head.	  All	  of	  these	  dogs	  had	  a	  fair	  limb	  use	  within	  2	  weeks,	  improving	  to	  good	  use	  within	  
2	  months	  in	  3	  dogs	  (dogs	  3,	  4,	  and	  28),	  suggesting	  that	  even	  with	  radical	  resection,	  this	  technique	  can	  result	  in	  a	  
functional	  limb.	  
Adjunctive	   chemotherapy	   was	   positively	   prognostic	   for	   both	   DFI	   and	   ST.	   Dogs	   treated	   with	   adjunctive	  
chemotherapy	  had	  a	  median	  ST	  of	  269	  (range,	  232-­‐919)	  days,	  compared	  with	  107	  (range,	  49-­‐122)	  days	  in	  dogs	  that	  
did	   not	   (P	   =	   .0003;	   HR=5.4;	   95%CI:2.2,	   13.5).	   Additionof	   chemotherapy	   to	   the	   treatment	   protocol	   was	   also	  
significantly	  associated	  with	  an	  increased	  DFI	  (211	  days)	  compared	  with	  52	  days	  for	  dogs	  that	  did	  not	  (P	  =	  .00011	  HR	  
=	  38.2;	  95%CI:	  4.2,	  339.7).	  Although	  there	  may	  be	  some	  selection	  bias	   involved	  because	  owners	  willing	  to	  treat	  
with	  chemotherapy	  may	  promote	  a	  longer	  treatment	  course	  before	  euthanasia,	  the	  significant	  survival	  advantage	  
afforded	   by	   chemotherapy	   has	   been	   documented	   previously	   in	   canine	   appendicular	   OSA,	   and	   our	   findings	  
confirm	   this.	   For	   scapular	   OSA,	   and	   other	   scapular	   tumors	  with	  metastatic	   potential,	   adjunctive	   treatment	   with	  
chemotherapy	   appears	   to	   be	   an	   appropriate	   recommendation.	   When	   OSA	   dogs	   alone	   were	   evaluated,	   this	  
positive	  effect	  on	  prognosis	  approached,	  but	  did	  not	  reach	  statistical	  significance	  (P	  =	  .056);	  however,	  given	  
this	   trend	  and	  current	   recommen-­‐dations	   for	   treatment	  of	  OSA,	  adjunctive	  chemotherapy	   is	  recommended	   for	  
treatment	  of	  dogs	  with	  scapular	  OSA.	  
In	  dogs	  monitored	  for	  metastasis,	  67%	  developed	  pulmonary	  metastasis,	  reflecting	  the	  high	  proportion	  of	  
OSA	  in	  these	  dogs.	  It	  appears	  from	  these	  findings	  that	  scapular	  OSA	  has	  similar	  behavior	  to	  appendicular	  OSA	  at	  
other	  sites.	  Regular	  monitoring	  of	  these	  dogs	  with	  thoracic	  radiographs	  is	  recommended.	  A	  dog	  with	  CSA	  had	  lungs	  
metastasis	  at	  the	  time	  of	  diagnosis	  and	  this	  dog	  had	  a	  long	  ST	  after	  surgery	  and	  chemotherapy.	  Overall	  DFI	  in	  our	  
study	  was	  204	  days	  and	  overall	  ST	  was	  246	  days.	  Again,	  the	  OSA	  cases	  had	  a	  major	  effect	  on	  our	  results,	  as	  the	  DFI	  
and	  median	   ST	   of	   dogs	  with	  OSA	   in	  was	   210	   days	   (range,	   118-­‐245	   days)	   and	   246	   days	   (range,	   77-­‐651	   days),	  
respectively.	  This	  is	  similar	  to	  the	  DFI	  and	  MST	  that	  would	  be	  expected	  after	  chemotherapy	  of	  appendicular	  OSA	  at	  
other	  locations.	  	  	  1	  
Preoperative	   incisional	   biopsy	   performed	   in	   27	   dogs	   had	   high	   diagnostic	   yield	   (26	   dogs)	   and	   results	   from	  
incisional	  biopsy	  were	  consistent	  with	  eventual	  diagnosis	  when	  the	  entire	  mass	  was	   submi^ed.	   In	   dog	   29,	   the	  
preopera5ve	  open	  incisional	  biopsy	  was	  not	  diagnostic.	  As	  most	  primary	  bone	  tumors	  require	  a	  wide	  resection	  
for	   curative	   intent	   treatment,	   regardless	   of	   histologic	   diagnosis,	   the	   decision	   to	   biopsy	   is	   somewhat	   clinician	  
dependent.	  Care	  must	  be	  taken	  during	  biopsy	  to	  ensure	  that	  the	  biopsy	  tract	  can	  be	  entirely	  removed	  with	  the	  
definitive	  resection.	  
Preopera5ve	  cytologic	  examina5on	  of	  fine	  needle	  aspirates	  was	  performed	  in	  11	  dogs	  (26%)	  with	  high	  yield;	  
results	  were	  consistent	  with	  the	  ultimate	  diagnosis	   in	  all	  cases.	  Cytology	  has	  been	  shown	  to	  be	  a	  good	   test	   for	  
evaluating	   appendicular	   bone	   lesions	   using	   fine	   needle	   aspiration,	  with	   a	   reported	   diagnostic	   accuracy	   of	   71%	  
overall	  and	  92%	  when	  a	  neoplastic	  process	  was	  identified.18	  Ultrasound-­‐guided	  fine	  needle	  aspirate	  for	  bone	  lesions	  
has	  also	  been	  reported	  to	  allow	  recognition	  of	  a	  break	  in	  the	  bone	  cortex	  for	  sampling,	  with	  a	  diagnostic	  sample	  
obtained	  in	  32/36	  cases	  in	  1	  study.19	  Fine	  needle	  aspirate	  for	  cytology	  could	  be	  considered	  as	  a	  first	  diagnostic	  step	  
for	  scapular	  tumors,	  because	  it	  may	  abrogate	  the	  need	  for	  incisional	  biopsy,	  thus	  contributing	  to	  lower	  patient	  
morbidity,	  decreased	  cost,	  and	  faster	  time	  for	  results.	  
Distribution	  of	  histologic	  diagnoses	  (63.3%	  OSA,	  16.7%	  STS,	  9.5%	  CSA,	  and	  9.5%	  other	  tumors)	  was	  consistent	  
with	  previous	  reports.	  OSA	  is	  the	  most	  common	  primary	  tumor	  in	  dogs,	  so	  this	  finding	  is	  not	  surprising	  because	  we	  
focused	  on	  primary	  tumors	  of	  the	  scapula.	  It	  was	  interesting	  to	  note	  that	  STS	  (7	  dogs),	  and	  not	  CSA	  (4	  dogs)	  was	  the	  
2nd	  most	  common	  primary	  tumor	  of	  bone	  in	  our	  dogs;	  however,	  given	  the	  low	  numbers	  of	  dogs	  in	  each	  group,	  
both	  should	  be	  considered	  as	  differential	  diagnoses	  for	  non-­‐OSA	  scapular	  tumors	  of	  dogs.	  The	  STS	  group	  can	  be	  
further	  divided	  into	  subtypes:	  3	  FSA,	  2	  grade	  II	  STS,	  1	  grade	  I	  STS,	  and	  1	  undifferentiated	  sarcoma.	  It	  is	  uncertain	  if	  
these	  were	  primary	   STSs	  of	  bone,	  or	   if	   they	  were	  STSs	   that	   arose	   adjacent	   to	   the	   scapula	  with	   bone	   invasion;	  
however,	  STS	  should	  be	  considered	  as	  a	  differential	  diagnosis	  in	  dogs	  with	  scapular	  tumors.	  
Histologic	  margins	  were	  considered	  complete	  in	  82.4%	  of	  dogs.	  This	  outcome	  is	  good	  overall,	  but	  because	  of	  
the	  high	  association	  between	  complete	  margins	  and	  a	  positive	  outcome	  for	  DFI	  and	  ST	  reported	  in	  other	  studies	  for	  
OSA,	   STS	  and	  CSA,	   a	  higher	   rate	  of	   complete	  histologic	  margins	   should	  be	   strived	   for.	   In	   evaluating	   rib	   tumors	  
treated	  with	   chest	  wall	   resec5on	   in	   dogs,	   both	   Liptak	   et	   al.20	   and	   Pirkey-­‐Ehrhart	   et	   al.	   21reported	   that	   the	  
margins	  of	  excision	  had	  a	  significant	  effect	  on	  patient	  survival.	  We	  did	  not	  find	  this	  effect,	  but	  this	  may	  be	  from	  type	  
II	  error	  because	  of	  small	  cases	  number	  and	  low	  statistical	  power.	  Use	  of	  advanced	  imaging	  for	  preopertive	  surgical	  
planning	  may	  improve	  the	  chances	  of	  achieving	  complete	  margins,	  as	  well	  as	  adhering	  strictly	  to	  the	  principles	  of	  
surgical	  oncology	  and	  wide	  excision.	  In	  our	  study,	  18	  dogs	  had	  preoperative	  3D	  imaging	  with	  either	  CT	  or	  MRI.	  This	  
relatively	  low	  rate	  may	  reflect	  the	  15-­‐year	  period	  of	  case	  accrual.	  We	  evaluated	  the	  effect	  of	  advanced	  imaging	  
on	  the	  ability	  to	  achieve	  complete	  margins	  of	  excision	  and	  did	  not	  find	  a	  signficant	  effect.	  Although	  not	  statistically	  
significant,	  we	  nevertheless	   recommend	  use	   of	   advanced	   imaging	   for	   preoperative	  planning	   to	  define	   tumor	  
margins	  and	  improve	  the	  likelihood	  of	  obtaining	  complete	  surgical	  margins	  at	  initial	  surgery.	  
The	  complica5on	  rate	  ater	  scapulectomy	  was	  low.	  Acute	  complica5ons	  included	  seroma	  (7	  dogs)	  and	  an	  
incisional	   breakdown	   at	   the	   level	   of	   the	   serratus	   ventralis.	   Scapulectomy	   will	   cause	   instability	   and	   increased	  
motion	   of	   the	   proximal	   aspect	   of	   the	   limb	   because	   of	   removal	   of	   the	   superficial	   muscles	   (omotrasversarius,	  
trapezius,	  deltoideous,	   supraspinatus,	   infraspinatus)	   and	   the	  deeper	  muscles	   (rhom-­‐boideus,	   seeratus	  ventralis,	  
subscapularis)	  that	  are	  disrupted	  in	  the	  resection.	  This	  surgical	  site	  should	  be	  reconstructed	  thoroughly,	  suturing	  
cut	  edges	  of	  the	  serratus	  ventralis	  and	  rhomboideus	  to	  the	  proximal	  edge	  of	  the	  subscapularis	  muscle	  and	  suturing	  
the	   dorsal	   borders	   of	   the	   remaninig	   infraspinatus	   and	   supraspinatus	  muscles	   to	   the	   insertion	   of	   the	   trapezius	  
muscle.	   The	   omotrasversarius	   and	   deltoideus	   muscles	   should	   be	   apposed	   when	   possible.2	   Careful	   soft	   tissue	  
reconstruction	   will	   decrease	   both	   dead	   space	   and	   motion	   and	   may	   help	   decrease	   seroma	   formation.	   Cold	  
compressive	  therapy,	  strict	  rest,	  and	  bandaging	  of	  the	  surgical	  site	  may	  help	  prevent	  acute	  complications.	  	  	  2	  
Chronic	   complications	   included	   seroma	   (2	   dogs),	   local	   recurrence	   (2	   confirmed,	   1	   suspected),	   and	  
pneumothorax	   in	   1	   dog	   that	   had	   a	   rib	   removed.	   The	   seromas	   were	   considered	   minor	   complications.	  
Pneumothorax	  was	  likely	  associated	  with	  the	  en	  bloc	  resection	  of	  the	  rib	  and	  not	  the	  scapulectomy	  procedure	  per	  
se.	  Local	  recurrence	  is	  a	  serious	  chronic	  complication.	  Overall,	  the	  complication	  rate	  was	  low,	  with	  seroma	  being	  
the	  most	  common	  acute	  and	  chronic	  complication	  reported.	  
Local	  recurrence	  was	  documented	  in	  2	  dogs	  and	  suspected	  in	  1	  dog.	  In	  cases	  of	  confirmed	  recurrence,	  1	  dog	  
had	  histologically	  complete	  margins	  after	  removal	  of	  a	  STS	  (FSA).	  The	  other	  dog	  had	  CSA	  on	  incisional	  biopsy,	  but	  
final	  histopathology	  was	  not	  available.	  It	  is	  not	  clear	  from	  the	  record,	  but	  it	  appears	  that	  the	  scapula	  was	  submitted	  for	  
histopathology	  postoperatively	  but	  the	  sample	  was	  lost.	  This	  case	  highlights	  the	  need	  to	  submit	  the	  entire	  sample	  
after	  definitive	   resection,	  even	  when	  a	  preoperative	  histologic	   diagnosis	   has	   been	  obtained.	  Histology	  on	   the	  
entire	  surgical	  specimen	  provides	  the	  definitive	  diagnosis,	  tumor	  grade,	  and	  an	  assessment	  of	  the	  surgical	  margins.	  
The	  3rd	  dog	  had	  OSA	  and	  incomplete	  histologic	  margins.	  This	  dog	  had	  lameness	  and	  swelling	  at	  the	  scapulectomy	  
site.	  Repeat	  CT	  scan	  was	  consistent	  with	  recurrence,	  but	  the	  biopsy	  failed	  to	  confirm	  recurrent	  disease.	  A	  repeat	  
biopsy	  would	  have	  been	  indicated,	  but	  was	  not	  performed.	  
Early	  postoperative	  (within	  2	  weeks)	   limb	  function	  was	  variable,	  but	  typically	  poor	  to	  fair	   immediately	  after	  
surgery,	  with	  improvement	  to	  fair	  or	  good	  by	  1	  month.	  For	  dogs	  with	  loger	  term	  assessment,	  further	  improvement	  
occurred	  in	  half	  of	  the	  dogs	  with	  poor	  limb	  use	  at	  1	  month	  and	  10/17	  of	  the	  dogs	  with	  fair	  limb	  use	  at	  1	  month.	  
Inconsistent	   follow	   up	   information	   and	   the	   subjectivity	   of	   limb	   use	   evaluation	   are	   acknowledged	   as	   study	  
limitations.	   A	   prospective	   study	   to	   evaluate	   limb	   use	   after	   scapulectomy	   with	   a	   longer	   follow	   up	   period	   and	  
objective,	  standardized	  evaluation	  of	  limb	  use,	  such	  as	  force	  plate	  analysis,	  would	  help	  to	  determine	  limb	  use	  more	  
accurately.	  
It	  is	  likely	  that	  after	  postoperative	  pain	  and	  swelling	  has	  decreased,	  these	  dogs	  require	  time	  to	  improve	  their	  
strength	  and	  coordination.	  Physiotherapy	  may	  play	  a	  role	  in	  improving	  limb	  function	  after	  scapulectomy.	  Although	  
only	  8	  dogs	  had	  physiotherapy,	  we	  found	  that	  the	  dogs	  that	  had	  physiotherapy	  had	  overall	  good	  limb	  function	  (3	  
fair,	  3	  good,	  and	  2	  excellent	  limb	  use).	  When	  limb	  use	  postoperatively	  and	  1	  month	  after	  surgery	  was	  assessed,	  
there	   was	   a	   significant	   association	   of	   decreased	   limb	   use	   with	   increasing	   weight,	   which	   confirms	   our	   clinical	  
impression	  that	  larger	  dogs	  will	  have	  a	  longer	  recovery	  after	  scapuectomy.	  It	  is	  likely,	  however,	  that	  as	  dogs	  increase	  in	  
weight,	   they	  will	   be	   less	   tolerant	   of	   amputation,	   so	   this	   finding	   should	  not	   deter	   clinicians	   from	   recommending	  
scapulectomy	  in	  large	  dogs.	  
Many	  (74%)	  dogs	  were	  administered	  adjunctive	  chemo-­‐therapy,	  likely	  reflecting	  the	  high	  proportion	  of	  dogs	  with	  
OSA	  (24/27).	  Of	  the	  4	  dogs	  with	  CSA,	  1	  received	  chemotherapy.	  Although	  earlier	  reports	  have	  suggested	  that	  CSA	  
has	  a	  low	  metastatic	  rate,	  a	  recent	  VSSO	  retrospective	  study	  evaluating	  canine	  appendicular	  CSA	  showed	  that	  28%	  
of	   dogs	   had	   metastatic	   disease	   and	   that	   histologic	   grade	   was	   predictive	   of	   metastasis	   and	   survival.	   14A	   50%	  
metastasis	   rate	  was	   reported	   for	   grade	   III	   CSA.14	   In	  people,	   grading	  CSA	   is	  one	  of	   the	  most	   important	   prognostic	  
factors,	  with	  a	  reported	  metastasis	  rate	  of	  71%	  for	  grade	  III	  CSA.24	  A	  grading	  scale	  adapted	  from	  a	  previous	  human	  
CSA	  grading	  scale,	  used	  by	  Farese	  et	  al.,	  was	  taken	  in	  considera5on	  in	  only	  1	  CSA	  case,	  which	  was	  diagnosed	  as	  
grade	  III	  CSA.	  This	  dog	  (dog	  35)	  developed	  pulmonary	  metastasis.	  Because	  of	  the	  small	  number	  of	  our	  dogs	  with	  
CSA,	  it	  is	  possible	  that	  this	  is	  not	  representative	  of	  the	  behavior	  of	  scapular	  CSA	  
Our	  study	  has	  several	  limitations	  inherent	  to	  retrospective	  studies.	  Inconsistencies	  in	  follow	  up	  and	  treatment	  
protocols	  existed.	  These	  limitations	  include:	  a	  nonstandardized	  chemo-­‐therapeutic	  protocol,	  lack	  of	  randomization	  
of	  the	  dogs	  into	  treatment	  group,	  and	  inconsistencies	  with	  case	  work-­‐up	  and	  staging	  and	  the	  number	  of	  non-­‐OSA	  
cases.	   Ideally,	   all	   the	  histopathologic	  samples	  would	  have	  been	  reviewed	  by	  a	  single	  pathologist	  and	  necroscopy	  
would	  have	  been	  performed	  on	  all	  dogs.	  It	  is	  possible	  that	  with	  a	  single	  pathologist	  review,	  some	  of	  the	  CSA	  cases	  
would	  have	  been	  reclassified	  as	  OSA	  and	  vice	  versa.	  We	  did	  not	  evaluate	  or	  report	  the	  surgical	  technique	  performed	  
in	  each	  dog	  for	  stabilizing	  the	  remaning	  part	  of	  the	  scapula	  musculature	  and	  chest	  wall,	  as	  this	  was	  considered	  
beyond	  the	  scope	  of	  our	  study.	  
We	  concluded	  that	  scapulectomy	  is	  a	  safe,	  well-­‐tolerated	  limb	  sparing	  procedure	  with	  a	  low	  complication	  rate.	  
Limb	  use	  was	  fair	  to	  excellent	  for	  most	  dogs	  and,	  although	  long-­‐terni	  follow	  up	  of	  limb	  use	  was	  not	  available	  in	  all	  
dogs,	  it	  appears	  that	  limb	  use	  improves	  over	  time.	  Increasing	  body	  weight	  is	  correlated	  with	  decreased	  limb	  use	  in	  
the	  early	  postoperative	  period.	  The	  most	  common	  scapular	  tumor	  was	  OSA,	  followed	  by	  STS,	  and	  CSA.	  Primarily	  
large	   breed	   dogs	   were	   affected,	   which	   is	   consistent	   with	   other	   locations	   for	   appendicular	   OSA	   and	   CSA.	   As	   is	  
expected	  with	  OSA	  at	  other	  sites,	  the	  addition	  of	  adjunctive	  chemotherapy	  significantly	  improved	  the	  DFI	  and	  MST.	  
SUPPORTING	  INFORMATION	  	  
Addi5onal	   suppor5ng	   informa5on	   may	   be	   found	   in	   the	   online	   version	   of	   this	   ar5cle	   at	   the	  
publisher’s	  web-­‐site.	  	  
ACKNOWLEDGMENTS	  
We	  thank	  Veterinary	  Society	  of	  Surgical	  Oncology	  (VSSO)	  members	  support	  for	  this	  study	  and	  especially	  Drs.	  
Julius	   Liptak,	   Maura	   O'Brien,	   Noel	   Fitzpatrick,	   Sarah	   Girling	   and	   Caleb	   Hudson	   and	   Nicholas	   Woo	   for	   case	  
submission.	  We	  thank	  Gabrielle	  Monteith	  for	  her	  assistance	  with	  statistical	  analysis.	  We	  would	  also	  like	  to	  thank	  
Dr.	  Stephen	  Withrow	  for	  his	  gentle	  encouragement	  of	  VSSO	  members	  for	  case	  accrual.	  
DISCLOSURE	  
The	  authors	  report	  no	  financial	  or	  other	  conflicts	  related	  to	  this	  report.	  
REFERENCES	  
1. Norton	  C,	  Drenen	  CM,	  Emms	  SG:	  Subtotal	  scapulectomy	  as	  the	  treatment	  for	  scapular	  tumour	  in	  the	  dog:	  a	  report	  of	  six	  cases.	  Aust	  Vet	   J	  
2006;84:364-­‐366.	  
2. Trout	  NJ,	   Pavletic	  MM,	  Kraus	  KH:	  Partial	   scapulectomy	   for	  management	  of	   sarcomas	   inthree	  dogs	  andtwo	  cats.	   J	  Am	  Vet	  Med	  Assoc	  
1995;207:585-­‐587.	  
3. Kirpensteijn	  J,	  Straw	  RC,	  Pardo	  AD,	  et	  al:	  Partial	  and	  total	  scapulectomy	  in	  the	  dog.	  J	  Am	  Anim	  Hosp	  Assoc	  1994;30:313—319.	  
4. Syme	  J:	  Excision	  of	  the	  scapula.	  Edinburgh,	  Scotland,	  Edmonston	  &	  Douglas,	  1864,	  pp	  11-­‐35.	  
5. Villalobos	  CE,	  Hayden	  BL,	  Silverman	  A,	  et	  al:	  Limb-­‐sparing	  resection	  of	  the	  scapula	  and	  reconstruction	  with	  constrained	  total	   scapula	  
prosthesis:	  a	  case	  of	  multicentric	  epithelioid	  hemangioendothelioma	  involving	  the	  scapula	  and	  surrounding	  soft	  tissues.	  Ann	  Surg	  Oncol	  
2009;16:2321-­‐2322.	  
6. Enneking	  WF:	  Musculoskeletal	  tumor	  surgery.	  Vol.	  1.	  New	  York,	  NY,	  Churchill	  Livingstone,	  1983,	  pp	  355-­‐410.	  
7. Creighton	  JJ	  Jr.,	  Peimer	  CA,	  Mindell	  ER,	  et	  al:	  Primary	  malignant	  tumors	  ofthe	  upper	  extremity:	  retrospective	  analysis	  of	  126	  cases.	  J	  Hand	  
Surg	  Am	  1985;10:805-­‐814.	  
8. Gibbons	  CLMH,	  Bell	  RS,	  Wundr	  JS,	  et	  al:	  Function	  after	  subtotal	  scapulectomy	  for	  neoplasm	  of	  bone	  and	  soft	  tissue.	  J	  Bone	  Joint 
Surg	  Br	  1998;80:38-­‐42.	  
9. Erdem	  V,	  Pead	  MJ:	  Haemangio	  sarcoma	  ofthe	  scapula	  in	  three	  dogs.	  JSmallAnim	  Pract	  2000;41:461-­‐464.	  
10. Dernell	  WS,	  Ehrhart	  NP,	  Straw	  RC,	  et	  al:	  Tumors	  ofthe	  skeletal	  system.	  in:	  Withrow	  SJ,	  Vail	  DM	  (eds):	  Withrow	  &	  MacEwen's 
small	  animal	  clinical	  oncology.	  (ed4).	  St	  Louis,	  MO,	  Saunders,	  2007,	  pp	  540-­‐582.	  
11. Hammer	  AS,	  Weeren	  FR,	  Weisbrode	  SE,	  et	  al:	  Prognostic	  factors	  in	  dogs	  with	  osteosarcoma	  ofthe	  flat	  and	  irregular	  bones.	  J	  Am 
Animal	  Hospital	  Assoc	  1995;31:321-­‐326.	  
12. Brodey	  RS,	  Misdorp	  W,	  Riser	  WH,	  et	  al:	  Canine	  skeletal	  chondrosarcoma	  a	  clinical	  pathology	  study	  of	  35	  cases.	  J	  Am	  Vet 
Medical	  Assoc	  1974;165:68-­‐78.	  
13. Waltman	   SS,	   Seguin	   B,	   Cooper	   B	   J,	   et	   al:	   Clinical	   outcome	   of	   non-­‐	   nasal	   chondrosarcoma	   in	   dogs:	   31	   cases	   (1986-­‐2003).	   Vet	   Surg	  
2007;36:266-­‐271.	  
13. Farese	   JP,	  Kirpensteijn	   J,	   Kik	  M,	  et	   al:	  Biologic	  behavior	   and	   clinical	  outcome	  of	  25	  dogs	  with	   canine	  appendicular	   chondrosarcoma	  
treated	  by	  amputation:	  a	  Veterinary	  Society	  of	  Surgical	  Oncology	  Retrospective	  Study.	  Vet	  Surg	  2009;38:914-­‐	  919.	  
14. Fox	  SM,	  Bray	  JC:	  Guerin	  SR,	  et	  al:	  Antebrachial	  deformities	  in	  the	  dog:	  treatment	  with	  external	  fixation.	  J	  Small	  Anim	  Pract	  1995;36:315-­‐320.	  
15. Bacon	  NJ,	   Ehrhart	  NP,	  Dernell	  WS,	   et	   al:	  Use	  of	   alternating	   administration	   of	   carboplatin	   and	   doxorubicin	   in	   dogs	  with	  microscopic	  
metastases	  after	  amputation	  for	  appendicular	  osteosarcoma:	  50	  cases	  (1999-­‐2006).	  J	  Am	  Vet	  Med	  Assoc	  2008;232:1504-­‐1510.	  
16. Kent	  MS,	  Strom	  A,	  London	  CA,	  et	  al:	  Alternating	  carboplatin	  and	  doxorubicin	  as	  adjunctive	  chemotherapy	  to	  amputation	  or	  limb-­‐sparing	  
surgery	  in	  the	  treatment	  of	  appendicular	  osteosarcoma	  in	  dogs.	  J	  Vet	  Intern	  Med	  2004;18:540-­‐544.	  
17. Berzina	  I,	  Sharkey	  LC,	  Matise	  I,	  et	  al:	  Correlation	  between	  cytologic	  and	  histopathologic	  diagnoses	  of	  bone	  lesions	  in	  dogs:	  a	  study	  of	  the	  
diagnostic	  accuracy	  of	  bone	  cytology.	  Vet	  Clin	  Pathol	  2008;37:332-­‐338.	  
18. Britt	  T,	  Clifford	  C,	  Barger	  A,	  et	  al:	  Diagnosing	  appendicular	  osteosarcoma	  with	  ultrasound-­‐guided	  fine-­‐needle	  aspiration:	  36	  cases.	  J	  Small	  
Anim	  Pract	  2007;48:145-­‐150.	  
19. Liptak	  JM,	  Kamstock	  DA,	  Dernell	  WS,	  et	  al:	  Oncologic	  outcome	  after	  curative-­‐intent	  treatment	  in	  39	  dogs	  with	  primary	  chest	  wall	  tumors	  
(1992-­‐2005).	  Vet	  Surg	  2008;37:488-­‐496.	  
20. Pirkey-­‐Ehrhart	  N,	  Withrow	  SJ,	  Straw	  RC	  et	  al:	  Primary	  ribs	  tumors	  in	  54	  dogs.	  J	  Am	  Anim	  Hosp	  Assoc	  1995;31:65-­‐69.	  
21. Drygas	   KA,	  McClure	   SR,	  Goring	  RL,	   et	   al:	   Effect	   of	   cold	   compression	   therapy	  on	  postoperative	  pain,	   swelling,	   range	  of	  motion,	   and	  
lameness	  after	  tibial	  plateau	  leveling	  osteotomy	  in	  dogs.	  J	  Am	  Vet	  Medical	  Assoc	  2011;238:1284-­‐1291.	  
22. Rexing	  J,	  Dunning	  D,	  Siegel	  AM,	  et	  al:	  Effects	  of	  cold	  compression,	  bandaging,	  and	  microcurrent	  electrical	  therapy	  after	  cranial	  cruciate	  
ligament	  repair	  in	  dogs.	  Vet	  Surg	  2010;39:54—58.	  
23. Evans	  HL,	  Ayala	  AG,	  Romsdahl	  MM:	  Prognostic	   factors	   in	   chondroasrcoma	  of	  bone:	  a	   clinicalpathological	   analysis	  with	  emphasys	   on	  
histologic	  grading.	  Cancer	  1977;40:818-­‐831.	  
  	  
Figure	  1	  Caudocranial	  projection	  of	  the	  left	  scapula	  from	  case	  41	  ;	  note	  an	  osteolytic	  expansile	  lesion	  with	  amorphous	  periostal	  reaction	  involving	  the	  medial	  
surface	  and	  the	  scapular	  spine	  with	  soft	  tissue	  swelling	  around.	  A	  subtotal	  scapulectomy	  was	  performed.	  
	  
Figure 2 Lateral radiographic projection of the scapulohumeral joint from dog 28 with scapular fibrosarcoma. Note lytic changes extending from the distal caudal 
aspect of the scapula to the glenoid cavity. Total scapulectomy with partial humeral head resection performed. 
 Figure 3    Postoperative limb use at 2 weeks compared to body weight. 
	  
	  	  
